Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

exposed

UPDATE Exposed: Aeras’ Film Series on Tuberculosis

Release of Chapter 1 of EXPOSED occured the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals - an MDR...

Watch Video

View All Videos »

MSF video

Multidrug-Resistance Tuberculosis: No Promises

A video from Medecins Sans Frontieres entitled "Multidrug-Resistance Tuberculosis: No Promises" on the situation of children affected with MDR-TB. It highlights the dire plight of children being treated for MDR-TB in Tajikistan....

Watch Video

View All Videos »

thumb206-andy

The Growing Landscape of TB Trials: Interview with Dr. Andrew Vernon

This week we highlight an interview with Dr. Andrew Vernon, the Chief, Clinical Research Branch, Division of Tuberculosis Elimination at the U.S. Centers for Disease Control and Prevention (CDC). He discusses the progress made in TB drug developmen...

Watch Video

View All Videos »

thumb206-lowrie

Immunotherapeutic Vaccines, TB and China: Interview with Dr. Douglas Lowrie

This week we highlight an interview with Dr. Douglas Lowrie, a Senior Research Fellow at Fudan University's Shanghai Public Health Clinical Center in China. He discusses the extent of the problem of TB in China and innovative research on enhancing ...

Watch Video

View All Videos »

previous next

Messages to our members

View All Messages »

From the blog

ncomms2898-i1

TB R&D Update: Vitamin C Kills Tuberculosis in vitro

This week we highlight a study out of William Jacobs, Jr.’s lab showing that “vitamin C, a compound known to drive the Fenton reaction, sterilizes cultures of drug-susceptible and drug-resistant Mycobacterium tuberculosis, the causative agent of tuberculosis.” Additional links to other news and articles related to TB R&D are included.

Posted 23 May 2013 | No Comments
exposed

UPDATE Exposed: Aeras’ Film Series on Tuberculosis

Release of Chapter 1 of EXPOSED occured the week of May 20. EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals – an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher – bringing viewers to the forefront of the race against tuberculosis. Click article to view the trailer and Chapter 1 “The Global Epidemic”.

Posted 15 May 2013 | No Comments

Get involved

Site features

Global Discovery Programs

An online tool that invites developers to submit their discovery programs so we can provide a more complete snapshot of current global efforts.

View Pipeline

The Global TB Drugs Pipeline

An online tool that invites developers to submit their TB drug candidates so we can provide a more complete snapshot of current global efforts.

View Pipeline

TB Resources Database

A growing collection of resources to help access Tools, Knowledge, Facilities, and People in the TB drug development R&D community.

View TB Resources

Why We Need New TB Drugs

Today's TB drug regimen takes too long to be effective and requires too many medications. Treatment of drug-sensitive disease requires 6-9 months whereas treatment of drug-resistant TB is even lengthier, taking 18-24 months or longer.

Read More

About us

Our Mission

To accelerate the discovery and development of new drugs for the treatment of tuberculosis by bringing together the stakeholders in TB Drug Development, including the patients themselves.
Read More »

Global Members

The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
Read More »

Total members: 227

WGND Members:

Heather Ignatius

TB Alliance

Bavesh Kana

University of the Witwatersrand/National Health Laboratory Service

Andrew Vernon

U.S. Centers for Disease Control and Prevention

Robert Bates

GlaxoSmithKline

Xuelian Zhang

Fudan University

Mamodikoe Makhene

NIH

Ann Ginsberg

TB Alliance

Philip Onyebujoh

WHO/Special Programme for Research and Training in Tropical Diseases (TDR)

Christopher Locher

Vertex Pharmaceuticals

Gail Tauscher

NIH, NIAID

View All Members »